The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial

• Published in: Journal of sleep research 2024-02, Vol.33 (1), p.e13982-n/a
• Main Authors: Maurer, Leonie Franziska, Sharman, Rachel, Espie, Colin Alexander, Kyle, Simon David
• Format: Article
• Language: English
• Subjects: Adult; Female; Humans; insomnia; Middle Aged; randomised controlled trial; rapid eye movement sleep; Sleep; Sleep Deprivation - complications; Sleep Deprivation - therapy; Sleep Initiation and Maintenance Disorders - therapy; sleep restriction therapy; Sleep, REM
• ISSN: 0962-1105; 1365-2869; 1365-2869
• DOI: 10.1111/jsr.13982

Summary Rapid eye movement sleep fragmentation is hypothesised to be a reliable feature of insomnia, which may contribute to emotion dysregulation. Sleep restriction therapy, an effective intervention for insomnia, has the potential to reduce rapid eye movement sleep fragmentation through its manipulation of basic sleep–wake processes. We performed secondary data analysis of a randomised controlled trial to examine whether sleep restriction therapy reduces rapid eye movement sleep fragmentation in comparison to a matched control arm. Participants (n = 56; 39 female, mean age = 40.78 ± 9.08 years) were randomly allocated to 4 weeks of sleep restriction therapy or 4 weeks of time in bed regularisation. Ambulatory polysomnographic recordings were performed at baseline, week 1 and week 4. Arousals during rapid eye movement and non‐rapid eye movement sleep were scored blind to group allocation. The following rapid eye movement sleep fragmentation index was the primary outcome: index 1 = (rapid eye movement arousals + rapid eye movement awakenings + non‐rapid eye movement intrusions)/rapid eye movement duration in hours. Secondary outcomes were two further indices of rapid eye movement sleep fragmentation: index 2 = (rapid eye movement arousals + rapid eye movement awakenings)/rapid eye movement duration in hours; and index 3 = rapid eye movement arousals/rapid eye movement duration in hours. A non‐rapid eye movement fragmentation index was also calculated (non‐rapid eye movement arousals/non‐rapid eye movement duration in hours). Linear‐mixed models were fitted to assess between‐group differences. There was no significant group difference for the primary rapid eye movement fragmentation index at week 1 (p = 0.097, d = −0.31) or week 4 (p = 0.741, d = −0.06). There was some indication that secondary indices of rapid eye movement fragmentation decreased more in the sleep restriction therapy group relative to control at week 1 (index 2: p = 0.023, d = −0.46; index 3: p = 0.051, d = −0.39), but not at week 4 (d ≤ 0.13). No group effects were found for arousals during non‐rapid eye movement sleep. We did not find clear evidence that sleep restriction therapy modifies rapid eye movement sleep fragmentation. Small‐to‐medium effect sizes in the hypothesised direction, across several indices of rapid eye movement fragmentation during early treatment, demand further investigation in future studies.